Global Nuclear Medicine Radioisotope Production Systems Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Nuclear Medicine Radioisotope Production Systems market size was valued at US$ 1046 million in 2025 and is forecast to a readjusted size of US$ 1991 million by 2032 with a CAGR of 9.7% during review period.
Nuclear Medicine Radioisotope Production Systems are integrated system level equipment used to produce, separate, process and prepare medical radionuclides for nuclear medicine diagnosis, therapy and radiopharmaceutical research. Their core function is to convert stable target materials, parent nuclides or precursor materials into clinically usable medical radioisotopes through particle acceleration, target irradiation, reactor neutron irradiation, generator elution, radiochemical separation, shielded transfer and automated dispensing. These systems mainly cover medical cyclotron systems, solid target systems, liquid target systems, gas target systems, radionuclide transfer systems, hot cells, shielded isolators, automated dispensing units, radiochemistry synthesis modules, generator and separation modules, quality control units, radiation monitoring devices, safety interlock systems and clean production infrastructure. Key specifications include particle energy, beam current, target power handling capacity, isotope yield, radiochemical purity, automation level, shielding thickness, cleanroom grade, system availability, remote maintenance capability and GMP compatibility. The main applications include PET diagnostic isotope production, SPECT diagnostic isotope production, therapeutic isotope production, parent isotope preparation, on site production in hospital nuclear medicine centers, regional supply by commercial radiopharmacies, national isotope center construction and translational research for radiopharmaceuticals. The product is positioned as a high reliability and high compliance production system rather than a single laboratory instrument, because it combines nuclear engineering, radiation protection, radiochemistry, pharmaceutical manufacturing and digital quality management. In 2025, the global average price of Nuclear Medicine Radioisotope Production Systems was approximately USD 2.5 million to USD 8.0 million per unit, the number of new and upgraded equivalent system units was about 150 to 220 units, and the global average gross margin was about 35% to 50%.
Nuclear Medicine Radioisotope Production Systems are positioned in the midstream equipment layer of the nuclear medicine value chain. The upstream side includes accelerator components, target materials, shielding materials, vacuum systems, RF systems, magnets, power supplies, hot cell materials, automation control, cleanroom engineering and quality control instruments. The midstream layer consists of radionuclide production systems, target systems, hot cells, generator platforms, separation modules and integrated production lines. The downstream side includes hospital nuclear medicine departments, commercial radiopharmacies, national isotope centers, radiopharmaceutical research organizations and therapeutic radiopharmaceutical production sites. The strategic value of this industry is not limited to the equipment itself. Its real value lies in the ability to create stable, safe and compliant isotope production capacity, while supporting the transition from diagnostic isotope supply to therapeutic isotope production and theranostic isotope platforms.
The global competitive landscape is shaped by both high technical specialization and regional supply chain restructuring. Europe, North America and Japan have accumulated strong capabilities in medical cyclotrons, high performance target systems, hot cells, radiochemistry automation and in reactor isotope production engineering. These regions still dominate the high end system and critical subsystem segments. China, parts of Asia and the Middle East are showing faster demand growth, supported by nuclear medicine center expansion, regional radiopharmacy construction, import substitution and broader healthcare infrastructure investment. As isotope supply security becomes a policy priority for healthcare systems and nuclear technology programs, more countries are investing in domestic production capacity. This trend is increasing the importance of localized, compact, modular and serviceable production systems.
The application structure is shifting from conventional PET diagnostic isotope production toward multi isotope production platforms. Historically, demand was mainly driven by routine PET and SPECT isotopes, with system configurations centered on low energy medical cyclotrons, hot cells and dispensing equipment. Current growth is increasingly linked to therapeutic isotopes, parent isotopes, solid target processing, generator separation and complete GMP production lines. Theranostic drugs, targeted radioligand therapy and the need for local supply of short lived isotopes are encouraging customers to move from single equipment purchases to system level investment. In the future product mix, high automation target systems, remote operated hot cells, digital batch records, automated synthesis and dispensing, and high activity handling capability will become more important.
Policy environment and capital expenditure cycles have a strong influence on this market. Medical isotope supply is connected with public health, nuclear safety, drug regulation, radiation protection and strategic supply security, so government support, nuclear facility licensing, hospital construction plans and radiopharmaceutical approval schedules all affect equipment procurement. Recent global isotope supply disruptions, aging reactor infrastructure, rising interest in therapeutic radiopharmaceuticals and the expansion of nuclear medicine services are moving the industry from occasional equipment purchases toward long term capacity building. The outlook is positive, but equipment market growth will not fully mirror the growth rate of radiopharmaceutical sales because system delivery cycles are long, installation and validation are complex, regulatory review is strict and customer capital spending is staged. Overall, the industry is expected to maintain steady growth, with high end system capability and localized supply support becoming the key competitive priorities.
This report is a detailed and comprehensive analysis for global Nuclear Medicine Radioisotope Production Systems market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Production Route and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Nuclear Medicine Radioisotope Production Systems market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Nuclear Medicine Radioisotope Production Systems market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Nuclear Medicine Radioisotope Production Systems market size and forecasts, by Production Route and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Nuclear Medicine Radioisotope Production Systems market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Nuclear Medicine Radioisotope Production Systems market is split by Production Route and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Production Route, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Production Route
Chapter 1, to describe Nuclear Medicine Radioisotope Production Systems product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Nuclear Medicine Radioisotope Production Systems, with price, sales quantity, revenue, and global market share of Nuclear Medicine Radioisotope Production Systems from 2021 to 2026.
Chapter 3, the Nuclear Medicine Radioisotope Production Systems competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nuclear Medicine Radioisotope Production Systems breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Production Route and by Application, with sales market share and growth rate by Production Route, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Nuclear Medicine Radioisotope Production Systems market forecast, by regions, by Production Route, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Nuclear Medicine Radioisotope Production Systems.
Chapter 14 and 15, to describe Nuclear Medicine Radioisotope Production Systems sales channel, distributors, customers, research findings and conclusion.
Nuclear Medicine Radioisotope Production Systems are integrated system level equipment used to produce, separate, process and prepare medical radionuclides for nuclear medicine diagnosis, therapy and radiopharmaceutical research. Their core function is to convert stable target materials, parent nuclides or precursor materials into clinically usable medical radioisotopes through particle acceleration, target irradiation, reactor neutron irradiation, generator elution, radiochemical separation, shielded transfer and automated dispensing. These systems mainly cover medical cyclotron systems, solid target systems, liquid target systems, gas target systems, radionuclide transfer systems, hot cells, shielded isolators, automated dispensing units, radiochemistry synthesis modules, generator and separation modules, quality control units, radiation monitoring devices, safety interlock systems and clean production infrastructure. Key specifications include particle energy, beam current, target power handling capacity, isotope yield, radiochemical purity, automation level, shielding thickness, cleanroom grade, system availability, remote maintenance capability and GMP compatibility. The main applications include PET diagnostic isotope production, SPECT diagnostic isotope production, therapeutic isotope production, parent isotope preparation, on site production in hospital nuclear medicine centers, regional supply by commercial radiopharmacies, national isotope center construction and translational research for radiopharmaceuticals. The product is positioned as a high reliability and high compliance production system rather than a single laboratory instrument, because it combines nuclear engineering, radiation protection, radiochemistry, pharmaceutical manufacturing and digital quality management. In 2025, the global average price of Nuclear Medicine Radioisotope Production Systems was approximately USD 2.5 million to USD 8.0 million per unit, the number of new and upgraded equivalent system units was about 150 to 220 units, and the global average gross margin was about 35% to 50%.
Nuclear Medicine Radioisotope Production Systems are positioned in the midstream equipment layer of the nuclear medicine value chain. The upstream side includes accelerator components, target materials, shielding materials, vacuum systems, RF systems, magnets, power supplies, hot cell materials, automation control, cleanroom engineering and quality control instruments. The midstream layer consists of radionuclide production systems, target systems, hot cells, generator platforms, separation modules and integrated production lines. The downstream side includes hospital nuclear medicine departments, commercial radiopharmacies, national isotope centers, radiopharmaceutical research organizations and therapeutic radiopharmaceutical production sites. The strategic value of this industry is not limited to the equipment itself. Its real value lies in the ability to create stable, safe and compliant isotope production capacity, while supporting the transition from diagnostic isotope supply to therapeutic isotope production and theranostic isotope platforms.
The global competitive landscape is shaped by both high technical specialization and regional supply chain restructuring. Europe, North America and Japan have accumulated strong capabilities in medical cyclotrons, high performance target systems, hot cells, radiochemistry automation and in reactor isotope production engineering. These regions still dominate the high end system and critical subsystem segments. China, parts of Asia and the Middle East are showing faster demand growth, supported by nuclear medicine center expansion, regional radiopharmacy construction, import substitution and broader healthcare infrastructure investment. As isotope supply security becomes a policy priority for healthcare systems and nuclear technology programs, more countries are investing in domestic production capacity. This trend is increasing the importance of localized, compact, modular and serviceable production systems.
The application structure is shifting from conventional PET diagnostic isotope production toward multi isotope production platforms. Historically, demand was mainly driven by routine PET and SPECT isotopes, with system configurations centered on low energy medical cyclotrons, hot cells and dispensing equipment. Current growth is increasingly linked to therapeutic isotopes, parent isotopes, solid target processing, generator separation and complete GMP production lines. Theranostic drugs, targeted radioligand therapy and the need for local supply of short lived isotopes are encouraging customers to move from single equipment purchases to system level investment. In the future product mix, high automation target systems, remote operated hot cells, digital batch records, automated synthesis and dispensing, and high activity handling capability will become more important.
Policy environment and capital expenditure cycles have a strong influence on this market. Medical isotope supply is connected with public health, nuclear safety, drug regulation, radiation protection and strategic supply security, so government support, nuclear facility licensing, hospital construction plans and radiopharmaceutical approval schedules all affect equipment procurement. Recent global isotope supply disruptions, aging reactor infrastructure, rising interest in therapeutic radiopharmaceuticals and the expansion of nuclear medicine services are moving the industry from occasional equipment purchases toward long term capacity building. The outlook is positive, but equipment market growth will not fully mirror the growth rate of radiopharmaceutical sales because system delivery cycles are long, installation and validation are complex, regulatory review is strict and customer capital spending is staged. Overall, the industry is expected to maintain steady growth, with high end system capability and localized supply support becoming the key competitive priorities.
This report is a detailed and comprehensive analysis for global Nuclear Medicine Radioisotope Production Systems market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Production Route and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Nuclear Medicine Radioisotope Production Systems market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Nuclear Medicine Radioisotope Production Systems market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Nuclear Medicine Radioisotope Production Systems market size and forecasts, by Production Route and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Nuclear Medicine Radioisotope Production Systems market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Nuclear Medicine Radioisotope Production Systems
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Nuclear Medicine Radioisotope Production Systems market is split by Production Route and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Production Route, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Production Route
- Cyclotron based Production Systems
- Reactor Irradiation Production Systems
- Generator and Separation Production Systems
- Electron Accelerator and Neutron Source Production Systems
- Others
- Compact Low Energy Systems (?20 MeV)
- Medium Energy Multi Isotope Systems (20 to 35 MeV)
- High Energy Isotope Production Systems (>35 MeV)
- Others
- Hospital Nuclear Medicine Centers
- Commercial Radiopharmacies
- National Isotope Production Centers
- Research Institutes and Universities
- Nuclear Reactor Facilities
- Radiopharmaceutical CDMO Sites
- Others
- Ion Beam Applications SA
- GE HealthCare Technologies Inc.
- Sumitomo Heavy Industries, Ltd.
- Advanced Cyclotron Systems Inc.
- Best Theratronics Ltd.
- PMB SAS
- Sichuan Longevous Beamtech Co., Ltd.
- China Institute of Atomic Energy
- ARTMS Inc.
- Comecer S.p.A.
- Tema Sinergie S.p.A.
- Von Gahlen International B.V.
- Trasis S.A.
- Eckert & Ziegler Medical GmbH
- Kinectrics Inc.
- Framatome
- NorthStar Medical Radioisotopes, LLC
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Nuclear Medicine Radioisotope Production Systems product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Nuclear Medicine Radioisotope Production Systems, with price, sales quantity, revenue, and global market share of Nuclear Medicine Radioisotope Production Systems from 2021 to 2026.
Chapter 3, the Nuclear Medicine Radioisotope Production Systems competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nuclear Medicine Radioisotope Production Systems breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Production Route and by Application, with sales market share and growth rate by Production Route, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Nuclear Medicine Radioisotope Production Systems market forecast, by regions, by Production Route, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Nuclear Medicine Radioisotope Production Systems.
Chapter 14 and 15, to describe Nuclear Medicine Radioisotope Production Systems sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Production Route
1.3.1 Overview: Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Production Route: 2021 Versus 2025 Versus 2032
1.3.2 Cyclotron based Production Systems
1.3.3 Reactor Irradiation Production Systems
1.3.4 Generator and Separation Production Systems
1.3.5 Electron Accelerator and Neutron Source Production Systems
1.3.6 Others
1.4 Market Analysis by Energy Level
1.4.1 Overview: Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Energy Level: 2021 Versus 2025 Versus 2032
1.4.2 Compact Low Energy Systems (?20 MeV)
1.4.3 Medium Energy Multi Isotope Systems (20 to 35 MeV)
1.4.4 High Energy Isotope Production Systems (>35 MeV)
1.4.5 Others
1.5 Market Analysis by Application
1.5.1 Overview: Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.5.2 Hospital Nuclear Medicine Centers
1.5.3 Commercial Radiopharmacies
1.5.4 National Isotope Production Centers
1.5.5 Research Institutes and Universities
1.5.6 Nuclear Reactor Facilities
1.5.7 Radiopharmaceutical CDMO Sites
1.5.8 Others
1.6 Global Nuclear Medicine Radioisotope Production Systems Market Size & Forecast
1.6.1 Global Nuclear Medicine Radioisotope Production Systems Consumption Value (2021 & 2025 & 2032)
1.6.2 Global Nuclear Medicine Radioisotope Production Systems Sales Quantity (2021-2032)
1.6.3 Global Nuclear Medicine Radioisotope Production Systems Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Ion Beam Applications SA
2.1.1 Ion Beam Applications SA Details
2.1.2 Ion Beam Applications SA Major Business
2.1.3 Ion Beam Applications SA Nuclear Medicine Radioisotope Production Systems Product and Services
2.1.4 Ion Beam Applications SA Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Ion Beam Applications SA Recent Developments/Updates
2.2 GE HealthCare Technologies Inc.
2.2.1 GE HealthCare Technologies Inc. Details
2.2.2 GE HealthCare Technologies Inc. Major Business
2.2.3 GE HealthCare Technologies Inc. Nuclear Medicine Radioisotope Production Systems Product and Services
2.2.4 GE HealthCare Technologies Inc. Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 GE HealthCare Technologies Inc. Recent Developments/Updates
2.3 Sumitomo Heavy Industries, Ltd.
2.3.1 Sumitomo Heavy Industries, Ltd. Details
2.3.2 Sumitomo Heavy Industries, Ltd. Major Business
2.3.3 Sumitomo Heavy Industries, Ltd. Nuclear Medicine Radioisotope Production Systems Product and Services
2.3.4 Sumitomo Heavy Industries, Ltd. Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Sumitomo Heavy Industries, Ltd. Recent Developments/Updates
2.4 Advanced Cyclotron Systems Inc.
2.4.1 Advanced Cyclotron Systems Inc. Details
2.4.2 Advanced Cyclotron Systems Inc. Major Business
2.4.3 Advanced Cyclotron Systems Inc. Nuclear Medicine Radioisotope Production Systems Product and Services
2.4.4 Advanced Cyclotron Systems Inc. Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Advanced Cyclotron Systems Inc. Recent Developments/Updates
2.5 Best Theratronics Ltd.
2.5.1 Best Theratronics Ltd. Details
2.5.2 Best Theratronics Ltd. Major Business
2.5.3 Best Theratronics Ltd. Nuclear Medicine Radioisotope Production Systems Product and Services
2.5.4 Best Theratronics Ltd. Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Best Theratronics Ltd. Recent Developments/Updates
2.6 PMB SAS
2.6.1 PMB SAS Details
2.6.2 PMB SAS Major Business
2.6.3 PMB SAS Nuclear Medicine Radioisotope Production Systems Product and Services
2.6.4 PMB SAS Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 PMB SAS Recent Developments/Updates
2.7 Sichuan Longevous Beamtech Co., Ltd.
2.7.1 Sichuan Longevous Beamtech Co., Ltd. Details
2.7.2 Sichuan Longevous Beamtech Co., Ltd. Major Business
2.7.3 Sichuan Longevous Beamtech Co., Ltd. Nuclear Medicine Radioisotope Production Systems Product and Services
2.7.4 Sichuan Longevous Beamtech Co., Ltd. Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Sichuan Longevous Beamtech Co., Ltd. Recent Developments/Updates
2.8 China Institute of Atomic Energy
2.8.1 China Institute of Atomic Energy Details
2.8.2 China Institute of Atomic Energy Major Business
2.8.3 China Institute of Atomic Energy Nuclear Medicine Radioisotope Production Systems Product and Services
2.8.4 China Institute of Atomic Energy Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 China Institute of Atomic Energy Recent Developments/Updates
2.9 ARTMS Inc.
2.9.1 ARTMS Inc. Details
2.9.2 ARTMS Inc. Major Business
2.9.3 ARTMS Inc. Nuclear Medicine Radioisotope Production Systems Product and Services
2.9.4 ARTMS Inc. Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 ARTMS Inc. Recent Developments/Updates
2.10 Comecer S.p.A.
2.10.1 Comecer S.p.A. Details
2.10.2 Comecer S.p.A. Major Business
2.10.3 Comecer S.p.A. Nuclear Medicine Radioisotope Production Systems Product and Services
2.10.4 Comecer S.p.A. Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Comecer S.p.A. Recent Developments/Updates
2.11 Tema Sinergie S.p.A.
2.11.1 Tema Sinergie S.p.A. Details
2.11.2 Tema Sinergie S.p.A. Major Business
2.11.3 Tema Sinergie S.p.A. Nuclear Medicine Radioisotope Production Systems Product and Services
2.11.4 Tema Sinergie S.p.A. Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Tema Sinergie S.p.A. Recent Developments/Updates
2.12 Von Gahlen International B.V.
2.12.1 Von Gahlen International B.V. Details
2.12.2 Von Gahlen International B.V. Major Business
2.12.3 Von Gahlen International B.V. Nuclear Medicine Radioisotope Production Systems Product and Services
2.12.4 Von Gahlen International B.V. Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Von Gahlen International B.V. Recent Developments/Updates
2.13 Trasis S.A.
2.13.1 Trasis S.A. Details
2.13.2 Trasis S.A. Major Business
2.13.3 Trasis S.A. Nuclear Medicine Radioisotope Production Systems Product and Services
2.13.4 Trasis S.A. Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Trasis S.A. Recent Developments/Updates
2.14 Eckert & Ziegler Medical GmbH
2.14.1 Eckert & Ziegler Medical GmbH Details
2.14.2 Eckert & Ziegler Medical GmbH Major Business
2.14.3 Eckert & Ziegler Medical GmbH Nuclear Medicine Radioisotope Production Systems Product and Services
2.14.4 Eckert & Ziegler Medical GmbH Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Eckert & Ziegler Medical GmbH Recent Developments/Updates
2.15 Kinectrics Inc.
2.15.1 Kinectrics Inc. Details
2.15.2 Kinectrics Inc. Major Business
2.15.3 Kinectrics Inc. Nuclear Medicine Radioisotope Production Systems Product and Services
2.15.4 Kinectrics Inc. Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Kinectrics Inc. Recent Developments/Updates
2.16 Framatome
2.16.1 Framatome Details
2.16.2 Framatome Major Business
2.16.3 Framatome Nuclear Medicine Radioisotope Production Systems Product and Services
2.16.4 Framatome Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Framatome Recent Developments/Updates
2.17 NorthStar Medical Radioisotopes, LLC
2.17.1 NorthStar Medical Radioisotopes, LLC Details
2.17.2 NorthStar Medical Radioisotopes, LLC Major Business
2.17.3 NorthStar Medical Radioisotopes, LLC Nuclear Medicine Radioisotope Production Systems Product and Services
2.17.4 NorthStar Medical Radioisotopes, LLC Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 NorthStar Medical Radioisotopes, LLC Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: NUCLEAR MEDICINE RADIOISOTOPE PRODUCTION SYSTEMS BY MANUFACTURER
3.1 Global Nuclear Medicine Radioisotope Production Systems Sales Quantity by Manufacturer (2021-2026)
3.2 Global Nuclear Medicine Radioisotope Production Systems Revenue by Manufacturer (2021-2026)
3.3 Global Nuclear Medicine Radioisotope Production Systems Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Nuclear Medicine Radioisotope Production Systems by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Nuclear Medicine Radioisotope Production Systems Manufacturer Market Share in 2025
3.4.3 Top 6 Nuclear Medicine Radioisotope Production Systems Manufacturer Market Share in 2025
3.5 Nuclear Medicine Radioisotope Production Systems Market: Overall Company Footprint Analysis
3.5.1 Nuclear Medicine Radioisotope Production Systems Market: Region Footprint
3.5.2 Nuclear Medicine Radioisotope Production Systems Market: Company Product Type Footprint
3.5.3 Nuclear Medicine Radioisotope Production Systems Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Nuclear Medicine Radioisotope Production Systems Market Size by Region
4.1.1 Global Nuclear Medicine Radioisotope Production Systems Sales Quantity by Region (2021-2032)
4.1.2 Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Region (2021-2032)
4.1.3 Global Nuclear Medicine Radioisotope Production Systems Average Price by Region (2021-2032)
4.2 North America Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032)
4.3 Europe Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032)
4.4 Asia-Pacific Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032)
4.5 South America Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032)
4.6 Middle East & Africa Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032)
5 MARKET SEGMENT BY PRODUCTION ROUTE
5.1 Global Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2021-2032)
5.2 Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Production Route (2021-2032)
5.3 Global Nuclear Medicine Radioisotope Production Systems Average Price by Production Route (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2021-2032)
6.2 Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Application (2021-2032)
6.3 Global Nuclear Medicine Radioisotope Production Systems Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2021-2032)
7.2 North America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2021-2032)
7.3 North America Nuclear Medicine Radioisotope Production Systems Market Size by Country
7.3.1 North America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Country (2021-2032)
7.3.2 North America Nuclear Medicine Radioisotope Production Systems Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2021-2032)
8.2 Europe Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2021-2032)
8.3 Europe Nuclear Medicine Radioisotope Production Systems Market Size by Country
8.3.1 Europe Nuclear Medicine Radioisotope Production Systems Sales Quantity by Country (2021-2032)
8.3.2 Europe Nuclear Medicine Radioisotope Production Systems Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2021-2032)
9.2 Asia-Pacific Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Nuclear Medicine Radioisotope Production Systems Market Size by Region
9.3.1 Asia-Pacific Nuclear Medicine Radioisotope Production Systems Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Nuclear Medicine Radioisotope Production Systems Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2021-2032)
10.2 South America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2021-2032)
10.3 South America Nuclear Medicine Radioisotope Production Systems Market Size by Country
10.3.1 South America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Country (2021-2032)
10.3.2 South America Nuclear Medicine Radioisotope Production Systems Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2021-2032)
11.2 Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Nuclear Medicine Radioisotope Production Systems Market Size by Country
11.3.1 Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Nuclear Medicine Radioisotope Production Systems Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Nuclear Medicine Radioisotope Production Systems Market Drivers
12.2 Nuclear Medicine Radioisotope Production Systems Market Restraints
12.3 Nuclear Medicine Radioisotope Production Systems Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Nuclear Medicine Radioisotope Production Systems and Key Manufacturers
13.2 Manufacturing Costs Percentage of Nuclear Medicine Radioisotope Production Systems
13.3 Nuclear Medicine Radioisotope Production Systems Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Nuclear Medicine Radioisotope Production Systems Typical Distributors
14.3 Nuclear Medicine Radioisotope Production Systems Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Production Route
1.3.1 Overview: Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Production Route: 2021 Versus 2025 Versus 2032
1.3.2 Cyclotron based Production Systems
1.3.3 Reactor Irradiation Production Systems
1.3.4 Generator and Separation Production Systems
1.3.5 Electron Accelerator and Neutron Source Production Systems
1.3.6 Others
1.4 Market Analysis by Energy Level
1.4.1 Overview: Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Energy Level: 2021 Versus 2025 Versus 2032
1.4.2 Compact Low Energy Systems (?20 MeV)
1.4.3 Medium Energy Multi Isotope Systems (20 to 35 MeV)
1.4.4 High Energy Isotope Production Systems (>35 MeV)
1.4.5 Others
1.5 Market Analysis by Application
1.5.1 Overview: Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.5.2 Hospital Nuclear Medicine Centers
1.5.3 Commercial Radiopharmacies
1.5.4 National Isotope Production Centers
1.5.5 Research Institutes and Universities
1.5.6 Nuclear Reactor Facilities
1.5.7 Radiopharmaceutical CDMO Sites
1.5.8 Others
1.6 Global Nuclear Medicine Radioisotope Production Systems Market Size & Forecast
1.6.1 Global Nuclear Medicine Radioisotope Production Systems Consumption Value (2021 & 2025 & 2032)
1.6.2 Global Nuclear Medicine Radioisotope Production Systems Sales Quantity (2021-2032)
1.6.3 Global Nuclear Medicine Radioisotope Production Systems Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Ion Beam Applications SA
2.1.1 Ion Beam Applications SA Details
2.1.2 Ion Beam Applications SA Major Business
2.1.3 Ion Beam Applications SA Nuclear Medicine Radioisotope Production Systems Product and Services
2.1.4 Ion Beam Applications SA Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Ion Beam Applications SA Recent Developments/Updates
2.2 GE HealthCare Technologies Inc.
2.2.1 GE HealthCare Technologies Inc. Details
2.2.2 GE HealthCare Technologies Inc. Major Business
2.2.3 GE HealthCare Technologies Inc. Nuclear Medicine Radioisotope Production Systems Product and Services
2.2.4 GE HealthCare Technologies Inc. Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 GE HealthCare Technologies Inc. Recent Developments/Updates
2.3 Sumitomo Heavy Industries, Ltd.
2.3.1 Sumitomo Heavy Industries, Ltd. Details
2.3.2 Sumitomo Heavy Industries, Ltd. Major Business
2.3.3 Sumitomo Heavy Industries, Ltd. Nuclear Medicine Radioisotope Production Systems Product and Services
2.3.4 Sumitomo Heavy Industries, Ltd. Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Sumitomo Heavy Industries, Ltd. Recent Developments/Updates
2.4 Advanced Cyclotron Systems Inc.
2.4.1 Advanced Cyclotron Systems Inc. Details
2.4.2 Advanced Cyclotron Systems Inc. Major Business
2.4.3 Advanced Cyclotron Systems Inc. Nuclear Medicine Radioisotope Production Systems Product and Services
2.4.4 Advanced Cyclotron Systems Inc. Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Advanced Cyclotron Systems Inc. Recent Developments/Updates
2.5 Best Theratronics Ltd.
2.5.1 Best Theratronics Ltd. Details
2.5.2 Best Theratronics Ltd. Major Business
2.5.3 Best Theratronics Ltd. Nuclear Medicine Radioisotope Production Systems Product and Services
2.5.4 Best Theratronics Ltd. Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Best Theratronics Ltd. Recent Developments/Updates
2.6 PMB SAS
2.6.1 PMB SAS Details
2.6.2 PMB SAS Major Business
2.6.3 PMB SAS Nuclear Medicine Radioisotope Production Systems Product and Services
2.6.4 PMB SAS Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 PMB SAS Recent Developments/Updates
2.7 Sichuan Longevous Beamtech Co., Ltd.
2.7.1 Sichuan Longevous Beamtech Co., Ltd. Details
2.7.2 Sichuan Longevous Beamtech Co., Ltd. Major Business
2.7.3 Sichuan Longevous Beamtech Co., Ltd. Nuclear Medicine Radioisotope Production Systems Product and Services
2.7.4 Sichuan Longevous Beamtech Co., Ltd. Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Sichuan Longevous Beamtech Co., Ltd. Recent Developments/Updates
2.8 China Institute of Atomic Energy
2.8.1 China Institute of Atomic Energy Details
2.8.2 China Institute of Atomic Energy Major Business
2.8.3 China Institute of Atomic Energy Nuclear Medicine Radioisotope Production Systems Product and Services
2.8.4 China Institute of Atomic Energy Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 China Institute of Atomic Energy Recent Developments/Updates
2.9 ARTMS Inc.
2.9.1 ARTMS Inc. Details
2.9.2 ARTMS Inc. Major Business
2.9.3 ARTMS Inc. Nuclear Medicine Radioisotope Production Systems Product and Services
2.9.4 ARTMS Inc. Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 ARTMS Inc. Recent Developments/Updates
2.10 Comecer S.p.A.
2.10.1 Comecer S.p.A. Details
2.10.2 Comecer S.p.A. Major Business
2.10.3 Comecer S.p.A. Nuclear Medicine Radioisotope Production Systems Product and Services
2.10.4 Comecer S.p.A. Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Comecer S.p.A. Recent Developments/Updates
2.11 Tema Sinergie S.p.A.
2.11.1 Tema Sinergie S.p.A. Details
2.11.2 Tema Sinergie S.p.A. Major Business
2.11.3 Tema Sinergie S.p.A. Nuclear Medicine Radioisotope Production Systems Product and Services
2.11.4 Tema Sinergie S.p.A. Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Tema Sinergie S.p.A. Recent Developments/Updates
2.12 Von Gahlen International B.V.
2.12.1 Von Gahlen International B.V. Details
2.12.2 Von Gahlen International B.V. Major Business
2.12.3 Von Gahlen International B.V. Nuclear Medicine Radioisotope Production Systems Product and Services
2.12.4 Von Gahlen International B.V. Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Von Gahlen International B.V. Recent Developments/Updates
2.13 Trasis S.A.
2.13.1 Trasis S.A. Details
2.13.2 Trasis S.A. Major Business
2.13.3 Trasis S.A. Nuclear Medicine Radioisotope Production Systems Product and Services
2.13.4 Trasis S.A. Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Trasis S.A. Recent Developments/Updates
2.14 Eckert & Ziegler Medical GmbH
2.14.1 Eckert & Ziegler Medical GmbH Details
2.14.2 Eckert & Ziegler Medical GmbH Major Business
2.14.3 Eckert & Ziegler Medical GmbH Nuclear Medicine Radioisotope Production Systems Product and Services
2.14.4 Eckert & Ziegler Medical GmbH Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Eckert & Ziegler Medical GmbH Recent Developments/Updates
2.15 Kinectrics Inc.
2.15.1 Kinectrics Inc. Details
2.15.2 Kinectrics Inc. Major Business
2.15.3 Kinectrics Inc. Nuclear Medicine Radioisotope Production Systems Product and Services
2.15.4 Kinectrics Inc. Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Kinectrics Inc. Recent Developments/Updates
2.16 Framatome
2.16.1 Framatome Details
2.16.2 Framatome Major Business
2.16.3 Framatome Nuclear Medicine Radioisotope Production Systems Product and Services
2.16.4 Framatome Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Framatome Recent Developments/Updates
2.17 NorthStar Medical Radioisotopes, LLC
2.17.1 NorthStar Medical Radioisotopes, LLC Details
2.17.2 NorthStar Medical Radioisotopes, LLC Major Business
2.17.3 NorthStar Medical Radioisotopes, LLC Nuclear Medicine Radioisotope Production Systems Product and Services
2.17.4 NorthStar Medical Radioisotopes, LLC Nuclear Medicine Radioisotope Production Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 NorthStar Medical Radioisotopes, LLC Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: NUCLEAR MEDICINE RADIOISOTOPE PRODUCTION SYSTEMS BY MANUFACTURER
3.1 Global Nuclear Medicine Radioisotope Production Systems Sales Quantity by Manufacturer (2021-2026)
3.2 Global Nuclear Medicine Radioisotope Production Systems Revenue by Manufacturer (2021-2026)
3.3 Global Nuclear Medicine Radioisotope Production Systems Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Nuclear Medicine Radioisotope Production Systems by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Nuclear Medicine Radioisotope Production Systems Manufacturer Market Share in 2025
3.4.3 Top 6 Nuclear Medicine Radioisotope Production Systems Manufacturer Market Share in 2025
3.5 Nuclear Medicine Radioisotope Production Systems Market: Overall Company Footprint Analysis
3.5.1 Nuclear Medicine Radioisotope Production Systems Market: Region Footprint
3.5.2 Nuclear Medicine Radioisotope Production Systems Market: Company Product Type Footprint
3.5.3 Nuclear Medicine Radioisotope Production Systems Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Nuclear Medicine Radioisotope Production Systems Market Size by Region
4.1.1 Global Nuclear Medicine Radioisotope Production Systems Sales Quantity by Region (2021-2032)
4.1.2 Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Region (2021-2032)
4.1.3 Global Nuclear Medicine Radioisotope Production Systems Average Price by Region (2021-2032)
4.2 North America Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032)
4.3 Europe Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032)
4.4 Asia-Pacific Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032)
4.5 South America Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032)
4.6 Middle East & Africa Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032)
5 MARKET SEGMENT BY PRODUCTION ROUTE
5.1 Global Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2021-2032)
5.2 Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Production Route (2021-2032)
5.3 Global Nuclear Medicine Radioisotope Production Systems Average Price by Production Route (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2021-2032)
6.2 Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Application (2021-2032)
6.3 Global Nuclear Medicine Radioisotope Production Systems Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2021-2032)
7.2 North America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2021-2032)
7.3 North America Nuclear Medicine Radioisotope Production Systems Market Size by Country
7.3.1 North America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Country (2021-2032)
7.3.2 North America Nuclear Medicine Radioisotope Production Systems Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2021-2032)
8.2 Europe Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2021-2032)
8.3 Europe Nuclear Medicine Radioisotope Production Systems Market Size by Country
8.3.1 Europe Nuclear Medicine Radioisotope Production Systems Sales Quantity by Country (2021-2032)
8.3.2 Europe Nuclear Medicine Radioisotope Production Systems Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2021-2032)
9.2 Asia-Pacific Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Nuclear Medicine Radioisotope Production Systems Market Size by Region
9.3.1 Asia-Pacific Nuclear Medicine Radioisotope Production Systems Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Nuclear Medicine Radioisotope Production Systems Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2021-2032)
10.2 South America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2021-2032)
10.3 South America Nuclear Medicine Radioisotope Production Systems Market Size by Country
10.3.1 South America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Country (2021-2032)
10.3.2 South America Nuclear Medicine Radioisotope Production Systems Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2021-2032)
11.2 Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Nuclear Medicine Radioisotope Production Systems Market Size by Country
11.3.1 Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Nuclear Medicine Radioisotope Production Systems Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Nuclear Medicine Radioisotope Production Systems Market Drivers
12.2 Nuclear Medicine Radioisotope Production Systems Market Restraints
12.3 Nuclear Medicine Radioisotope Production Systems Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Nuclear Medicine Radioisotope Production Systems and Key Manufacturers
13.2 Manufacturing Costs Percentage of Nuclear Medicine Radioisotope Production Systems
13.3 Nuclear Medicine Radioisotope Production Systems Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Nuclear Medicine Radioisotope Production Systems Typical Distributors
14.3 Nuclear Medicine Radioisotope Production Systems Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Production Route, (USD Million), 2021 & 2025 & 2032
Table 2. Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Energy Level, (USD Million), 2021 & 2025 & 2032
Table 3. Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 4. Ion Beam Applications SA Basic Information, Manufacturing Base and Competitors
Table 5. Ion Beam Applications SA Major Business
Table 6. Ion Beam Applications SA Nuclear Medicine Radioisotope Production Systems Product and Services
Table 7. Ion Beam Applications SA Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 8. Ion Beam Applications SA Recent Developments/Updates
Table 9. GE HealthCare Technologies Inc. Basic Information, Manufacturing Base and Competitors
Table 10. GE HealthCare Technologies Inc. Major Business
Table 11. GE HealthCare Technologies Inc. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 12. GE HealthCare Technologies Inc. Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 13. GE HealthCare Technologies Inc. Recent Developments/Updates
Table 14. Sumitomo Heavy Industries, Ltd. Basic Information, Manufacturing Base and Competitors
Table 15. Sumitomo Heavy Industries, Ltd. Major Business
Table 16. Sumitomo Heavy Industries, Ltd. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 17. Sumitomo Heavy Industries, Ltd. Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 18. Sumitomo Heavy Industries, Ltd. Recent Developments/Updates
Table 19. Advanced Cyclotron Systems Inc. Basic Information, Manufacturing Base and Competitors
Table 20. Advanced Cyclotron Systems Inc. Major Business
Table 21. Advanced Cyclotron Systems Inc. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 22. Advanced Cyclotron Systems Inc. Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. Advanced Cyclotron Systems Inc. Recent Developments/Updates
Table 24. Best Theratronics Ltd. Basic Information, Manufacturing Base and Competitors
Table 25. Best Theratronics Ltd. Major Business
Table 26. Best Theratronics Ltd. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 27. Best Theratronics Ltd. Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Best Theratronics Ltd. Recent Developments/Updates
Table 29. PMB SAS Basic Information, Manufacturing Base and Competitors
Table 30. PMB SAS Major Business
Table 31. PMB SAS Nuclear Medicine Radioisotope Production Systems Product and Services
Table 32. PMB SAS Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. PMB SAS Recent Developments/Updates
Table 34. Sichuan Longevous Beamtech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 35. Sichuan Longevous Beamtech Co., Ltd. Major Business
Table 36. Sichuan Longevous Beamtech Co., Ltd. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 37. Sichuan Longevous Beamtech Co., Ltd. Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Sichuan Longevous Beamtech Co., Ltd. Recent Developments/Updates
Table 39. China Institute of Atomic Energy Basic Information, Manufacturing Base and Competitors
Table 40. China Institute of Atomic Energy Major Business
Table 41. China Institute of Atomic Energy Nuclear Medicine Radioisotope Production Systems Product and Services
Table 42. China Institute of Atomic Energy Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. China Institute of Atomic Energy Recent Developments/Updates
Table 44. ARTMS Inc. Basic Information, Manufacturing Base and Competitors
Table 45. ARTMS Inc. Major Business
Table 46. ARTMS Inc. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 47. ARTMS Inc. Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. ARTMS Inc. Recent Developments/Updates
Table 49. Comecer S.p.A. Basic Information, Manufacturing Base and Competitors
Table 50. Comecer S.p.A. Major Business
Table 51. Comecer S.p.A. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 52. Comecer S.p.A. Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. Comecer S.p.A. Recent Developments/Updates
Table 54. Tema Sinergie S.p.A. Basic Information, Manufacturing Base and Competitors
Table 55. Tema Sinergie S.p.A. Major Business
Table 56. Tema Sinergie S.p.A. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 57. Tema Sinergie S.p.A. Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. Tema Sinergie S.p.A. Recent Developments/Updates
Table 59. Von Gahlen International B.V. Basic Information, Manufacturing Base and Competitors
Table 60. Von Gahlen International B.V. Major Business
Table 61. Von Gahlen International B.V. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 62. Von Gahlen International B.V. Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 63. Von Gahlen International B.V. Recent Developments/Updates
Table 64. Trasis S.A. Basic Information, Manufacturing Base and Competitors
Table 65. Trasis S.A. Major Business
Table 66. Trasis S.A. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 67. Trasis S.A. Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 68. Trasis S.A. Recent Developments/Updates
Table 69. Eckert & Ziegler Medical GmbH Basic Information, Manufacturing Base and Competitors
Table 70. Eckert & Ziegler Medical GmbH Major Business
Table 71. Eckert & Ziegler Medical GmbH Nuclear Medicine Radioisotope Production Systems Product and Services
Table 72. Eckert & Ziegler Medical GmbH Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 73. Eckert & Ziegler Medical GmbH Recent Developments/Updates
Table 74. Kinectrics Inc. Basic Information, Manufacturing Base and Competitors
Table 75. Kinectrics Inc. Major Business
Table 76. Kinectrics Inc. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 77. Kinectrics Inc. Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Kinectrics Inc. Recent Developments/Updates
Table 79. Framatome Basic Information, Manufacturing Base and Competitors
Table 80. Framatome Major Business
Table 81. Framatome Nuclear Medicine Radioisotope Production Systems Product and Services
Table 82. Framatome Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. Framatome Recent Developments/Updates
Table 84. NorthStar Medical Radioisotopes, LLC Basic Information, Manufacturing Base and Competitors
Table 85. NorthStar Medical Radioisotopes, LLC Major Business
Table 86. NorthStar Medical Radioisotopes, LLC Nuclear Medicine Radioisotope Production Systems Product and Services
Table 87. NorthStar Medical Radioisotopes, LLC Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 88. NorthStar Medical Radioisotopes, LLC Recent Developments/Updates
Table 89. Global Nuclear Medicine Radioisotope Production Systems Sales Quantity by Manufacturer (2021-2026) & (Units)
Table 90. Global Nuclear Medicine Radioisotope Production Systems Revenue by Manufacturer (2021-2026) & (USD Million)
Table 91. Global Nuclear Medicine Radioisotope Production Systems Average Price by Manufacturer (2021-2026) & (K US$/Unit)
Table 92. Market Position of Manufacturers in Nuclear Medicine Radioisotope Production Systems, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 93. Head Office and Nuclear Medicine Radioisotope Production Systems Production Site of Key Manufacturer
Table 94. Nuclear Medicine Radioisotope Production Systems Market: Company Product Type Footprint
Table 95. Nuclear Medicine Radioisotope Production Systems Market: Company Product Application Footprint
Table 96. Nuclear Medicine Radioisotope Production Systems New Market Entrants and Barriers to Market Entry
Table 97. Nuclear Medicine Radioisotope Production Systems Mergers, Acquisition, Agreements, and Collaborations
Table 98. Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 99. Global Nuclear Medicine Radioisotope Production Systems Sales Quantity by Region (2021-2026) & (Units)
Table 100. Global Nuclear Medicine Radioisotope Production Systems Sales Quantity by Region (2027-2032) & (Units)
Table 101. Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Region (2021-2026) & (USD Million)
Table 102. Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Region (2027-2032) & (USD Million)
Table 103. Global Nuclear Medicine Radioisotope Production Systems Average Price by Region (2021-2026) & (K US$/Unit)
Table 104. Global Nuclear Medicine Radioisotope Production Systems Average Price by Region (2027-2032) & (K US$/Unit)
Table 105. Global Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2021-2026) & (Units)
Table 106. Global Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2027-2032) & (Units)
Table 107. Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Production Route (2021-2026) & (USD Million)
Table 108. Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Production Route (2027-2032) & (USD Million)
Table 109. Global Nuclear Medicine Radioisotope Production Systems Average Price by Production Route (2021-2026) & (K US$/Unit)
Table 110. Global Nuclear Medicine Radioisotope Production Systems Average Price by Production Route (2027-2032) & (K US$/Unit)
Table 111. Global Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2021-2026) & (Units)
Table 112. Global Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2027-2032) & (Units)
Table 113. Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Application (2021-2026) & (USD Million)
Table 114. Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Application (2027-2032) & (USD Million)
Table 115. Global Nuclear Medicine Radioisotope Production Systems Average Price by Application (2021-2026) & (K US$/Unit)
Table 116. Global Nuclear Medicine Radioisotope Production Systems Average Price by Application (2027-2032) & (K US$/Unit)
Table 117. North America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2021-2026) & (Units)
Table 118. North America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2027-2032) & (Units)
Table 119. North America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2021-2026) & (Units)
Table 120. North America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2027-2032) & (Units)
Table 121. North America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Country (2021-2026) & (Units)
Table 122. North America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Country (2027-2032) & (Units)
Table 123. North America Nuclear Medicine Radioisotope Production Systems Consumption Value by Country (2021-2026) & (USD Million)
Table 124. North America Nuclear Medicine Radioisotope Production Systems Consumption Value by Country (2027-2032) & (USD Million)
Table 125. Europe Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2021-2026) & (Units)
Table 126. Europe Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2027-2032) & (Units)
Table 127. Europe Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2021-2026) & (Units)
Table 128. Europe Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2027-2032) & (Units)
Table 129. Europe Nuclear Medicine Radioisotope Production Systems Sales Quantity by Country (2021-2026) & (Units)
Table 130. Europe Nuclear Medicine Radioisotope Production Systems Sales Quantity by Country (2027-2032) & (Units)
Table 131. Europe Nuclear Medicine Radioisotope Production Systems Consumption Value by Country (2021-2026) & (USD Million)
Table 132. Europe Nuclear Medicine Radioisotope Production Systems Consumption Value by Country (2027-2032) & (USD Million)
Table 133. Asia-Pacific Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2021-2026) & (Units)
Table 134. Asia-Pacific Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2027-2032) & (Units)
Table 135. Asia-Pacific Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2021-2026) & (Units)
Table 136. Asia-Pacific Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2027-2032) & (Units)
Table 137. Asia-Pacific Nuclear Medicine Radioisotope Production Systems Sales Quantity by Region (2021-2026) & (Units)
Table 138. Asia-Pacific Nuclear Medicine Radioisotope Production Systems Sales Quantity by Region (2027-2032) & (Units)
Table 139. Asia-Pacific Nuclear Medicine Radioisotope Production Systems Consumption Value by Region (2021-2026) & (USD Million)
Table 140. Asia-Pacific Nuclear Medicine Radioisotope Production Systems Consumption Value by Region (2027-2032) & (USD Million)
Table 141. South America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2021-2026) & (Units)
Table 142. South America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2027-2032) & (Units)
Table 143. South America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2021-2026) & (Units)
Table 144. South America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2027-2032) & (Units)
Table 145. South America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Country (2021-2026) & (Units)
Table 146. South America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Country (2027-2032) & (Units)
Table 147. South America Nuclear Medicine Radioisotope Production Systems Consumption Value by Country (2021-2026) & (USD Million)
Table 148. South America Nuclear Medicine Radioisotope Production Systems Consumption Value by Country (2027-2032) & (USD Million)
Table 149. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2021-2026) & (Units)
Table 150. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2027-2032) & (Units)
Table 151. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2021-2026) & (Units)
Table 152. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2027-2032) & (Units)
Table 153. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Quantity by Country (2021-2026) & (Units)
Table 154. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Quantity by Country (2027-2032) & (Units)
Table 155. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Consumption Value by Country (2021-2026) & (USD Million)
Table 156. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Consumption Value by Country (2027-2032) & (USD Million)
Table 157. Nuclear Medicine Radioisotope Production Systems Raw Material
Table 158. Key Manufacturers of Nuclear Medicine Radioisotope Production Systems Raw Materials
Table 159. Nuclear Medicine Radioisotope Production Systems Typical Distributors
Table 160. Nuclear Medicine Radioisotope Production Systems Typical Customers
Table 1. Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Production Route, (USD Million), 2021 & 2025 & 2032
Table 2. Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Energy Level, (USD Million), 2021 & 2025 & 2032
Table 3. Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 4. Ion Beam Applications SA Basic Information, Manufacturing Base and Competitors
Table 5. Ion Beam Applications SA Major Business
Table 6. Ion Beam Applications SA Nuclear Medicine Radioisotope Production Systems Product and Services
Table 7. Ion Beam Applications SA Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 8. Ion Beam Applications SA Recent Developments/Updates
Table 9. GE HealthCare Technologies Inc. Basic Information, Manufacturing Base and Competitors
Table 10. GE HealthCare Technologies Inc. Major Business
Table 11. GE HealthCare Technologies Inc. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 12. GE HealthCare Technologies Inc. Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 13. GE HealthCare Technologies Inc. Recent Developments/Updates
Table 14. Sumitomo Heavy Industries, Ltd. Basic Information, Manufacturing Base and Competitors
Table 15. Sumitomo Heavy Industries, Ltd. Major Business
Table 16. Sumitomo Heavy Industries, Ltd. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 17. Sumitomo Heavy Industries, Ltd. Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 18. Sumitomo Heavy Industries, Ltd. Recent Developments/Updates
Table 19. Advanced Cyclotron Systems Inc. Basic Information, Manufacturing Base and Competitors
Table 20. Advanced Cyclotron Systems Inc. Major Business
Table 21. Advanced Cyclotron Systems Inc. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 22. Advanced Cyclotron Systems Inc. Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. Advanced Cyclotron Systems Inc. Recent Developments/Updates
Table 24. Best Theratronics Ltd. Basic Information, Manufacturing Base and Competitors
Table 25. Best Theratronics Ltd. Major Business
Table 26. Best Theratronics Ltd. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 27. Best Theratronics Ltd. Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Best Theratronics Ltd. Recent Developments/Updates
Table 29. PMB SAS Basic Information, Manufacturing Base and Competitors
Table 30. PMB SAS Major Business
Table 31. PMB SAS Nuclear Medicine Radioisotope Production Systems Product and Services
Table 32. PMB SAS Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. PMB SAS Recent Developments/Updates
Table 34. Sichuan Longevous Beamtech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 35. Sichuan Longevous Beamtech Co., Ltd. Major Business
Table 36. Sichuan Longevous Beamtech Co., Ltd. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 37. Sichuan Longevous Beamtech Co., Ltd. Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Sichuan Longevous Beamtech Co., Ltd. Recent Developments/Updates
Table 39. China Institute of Atomic Energy Basic Information, Manufacturing Base and Competitors
Table 40. China Institute of Atomic Energy Major Business
Table 41. China Institute of Atomic Energy Nuclear Medicine Radioisotope Production Systems Product and Services
Table 42. China Institute of Atomic Energy Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. China Institute of Atomic Energy Recent Developments/Updates
Table 44. ARTMS Inc. Basic Information, Manufacturing Base and Competitors
Table 45. ARTMS Inc. Major Business
Table 46. ARTMS Inc. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 47. ARTMS Inc. Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. ARTMS Inc. Recent Developments/Updates
Table 49. Comecer S.p.A. Basic Information, Manufacturing Base and Competitors
Table 50. Comecer S.p.A. Major Business
Table 51. Comecer S.p.A. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 52. Comecer S.p.A. Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. Comecer S.p.A. Recent Developments/Updates
Table 54. Tema Sinergie S.p.A. Basic Information, Manufacturing Base and Competitors
Table 55. Tema Sinergie S.p.A. Major Business
Table 56. Tema Sinergie S.p.A. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 57. Tema Sinergie S.p.A. Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. Tema Sinergie S.p.A. Recent Developments/Updates
Table 59. Von Gahlen International B.V. Basic Information, Manufacturing Base and Competitors
Table 60. Von Gahlen International B.V. Major Business
Table 61. Von Gahlen International B.V. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 62. Von Gahlen International B.V. Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 63. Von Gahlen International B.V. Recent Developments/Updates
Table 64. Trasis S.A. Basic Information, Manufacturing Base and Competitors
Table 65. Trasis S.A. Major Business
Table 66. Trasis S.A. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 67. Trasis S.A. Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 68. Trasis S.A. Recent Developments/Updates
Table 69. Eckert & Ziegler Medical GmbH Basic Information, Manufacturing Base and Competitors
Table 70. Eckert & Ziegler Medical GmbH Major Business
Table 71. Eckert & Ziegler Medical GmbH Nuclear Medicine Radioisotope Production Systems Product and Services
Table 72. Eckert & Ziegler Medical GmbH Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 73. Eckert & Ziegler Medical GmbH Recent Developments/Updates
Table 74. Kinectrics Inc. Basic Information, Manufacturing Base and Competitors
Table 75. Kinectrics Inc. Major Business
Table 76. Kinectrics Inc. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 77. Kinectrics Inc. Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Kinectrics Inc. Recent Developments/Updates
Table 79. Framatome Basic Information, Manufacturing Base and Competitors
Table 80. Framatome Major Business
Table 81. Framatome Nuclear Medicine Radioisotope Production Systems Product and Services
Table 82. Framatome Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. Framatome Recent Developments/Updates
Table 84. NorthStar Medical Radioisotopes, LLC Basic Information, Manufacturing Base and Competitors
Table 85. NorthStar Medical Radioisotopes, LLC Major Business
Table 86. NorthStar Medical Radioisotopes, LLC Nuclear Medicine Radioisotope Production Systems Product and Services
Table 87. NorthStar Medical Radioisotopes, LLC Nuclear Medicine Radioisotope Production Systems Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 88. NorthStar Medical Radioisotopes, LLC Recent Developments/Updates
Table 89. Global Nuclear Medicine Radioisotope Production Systems Sales Quantity by Manufacturer (2021-2026) & (Units)
Table 90. Global Nuclear Medicine Radioisotope Production Systems Revenue by Manufacturer (2021-2026) & (USD Million)
Table 91. Global Nuclear Medicine Radioisotope Production Systems Average Price by Manufacturer (2021-2026) & (K US$/Unit)
Table 92. Market Position of Manufacturers in Nuclear Medicine Radioisotope Production Systems, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 93. Head Office and Nuclear Medicine Radioisotope Production Systems Production Site of Key Manufacturer
Table 94. Nuclear Medicine Radioisotope Production Systems Market: Company Product Type Footprint
Table 95. Nuclear Medicine Radioisotope Production Systems Market: Company Product Application Footprint
Table 96. Nuclear Medicine Radioisotope Production Systems New Market Entrants and Barriers to Market Entry
Table 97. Nuclear Medicine Radioisotope Production Systems Mergers, Acquisition, Agreements, and Collaborations
Table 98. Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 99. Global Nuclear Medicine Radioisotope Production Systems Sales Quantity by Region (2021-2026) & (Units)
Table 100. Global Nuclear Medicine Radioisotope Production Systems Sales Quantity by Region (2027-2032) & (Units)
Table 101. Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Region (2021-2026) & (USD Million)
Table 102. Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Region (2027-2032) & (USD Million)
Table 103. Global Nuclear Medicine Radioisotope Production Systems Average Price by Region (2021-2026) & (K US$/Unit)
Table 104. Global Nuclear Medicine Radioisotope Production Systems Average Price by Region (2027-2032) & (K US$/Unit)
Table 105. Global Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2021-2026) & (Units)
Table 106. Global Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2027-2032) & (Units)
Table 107. Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Production Route (2021-2026) & (USD Million)
Table 108. Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Production Route (2027-2032) & (USD Million)
Table 109. Global Nuclear Medicine Radioisotope Production Systems Average Price by Production Route (2021-2026) & (K US$/Unit)
Table 110. Global Nuclear Medicine Radioisotope Production Systems Average Price by Production Route (2027-2032) & (K US$/Unit)
Table 111. Global Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2021-2026) & (Units)
Table 112. Global Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2027-2032) & (Units)
Table 113. Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Application (2021-2026) & (USD Million)
Table 114. Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Application (2027-2032) & (USD Million)
Table 115. Global Nuclear Medicine Radioisotope Production Systems Average Price by Application (2021-2026) & (K US$/Unit)
Table 116. Global Nuclear Medicine Radioisotope Production Systems Average Price by Application (2027-2032) & (K US$/Unit)
Table 117. North America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2021-2026) & (Units)
Table 118. North America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2027-2032) & (Units)
Table 119. North America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2021-2026) & (Units)
Table 120. North America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2027-2032) & (Units)
Table 121. North America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Country (2021-2026) & (Units)
Table 122. North America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Country (2027-2032) & (Units)
Table 123. North America Nuclear Medicine Radioisotope Production Systems Consumption Value by Country (2021-2026) & (USD Million)
Table 124. North America Nuclear Medicine Radioisotope Production Systems Consumption Value by Country (2027-2032) & (USD Million)
Table 125. Europe Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2021-2026) & (Units)
Table 126. Europe Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2027-2032) & (Units)
Table 127. Europe Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2021-2026) & (Units)
Table 128. Europe Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2027-2032) & (Units)
Table 129. Europe Nuclear Medicine Radioisotope Production Systems Sales Quantity by Country (2021-2026) & (Units)
Table 130. Europe Nuclear Medicine Radioisotope Production Systems Sales Quantity by Country (2027-2032) & (Units)
Table 131. Europe Nuclear Medicine Radioisotope Production Systems Consumption Value by Country (2021-2026) & (USD Million)
Table 132. Europe Nuclear Medicine Radioisotope Production Systems Consumption Value by Country (2027-2032) & (USD Million)
Table 133. Asia-Pacific Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2021-2026) & (Units)
Table 134. Asia-Pacific Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2027-2032) & (Units)
Table 135. Asia-Pacific Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2021-2026) & (Units)
Table 136. Asia-Pacific Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2027-2032) & (Units)
Table 137. Asia-Pacific Nuclear Medicine Radioisotope Production Systems Sales Quantity by Region (2021-2026) & (Units)
Table 138. Asia-Pacific Nuclear Medicine Radioisotope Production Systems Sales Quantity by Region (2027-2032) & (Units)
Table 139. Asia-Pacific Nuclear Medicine Radioisotope Production Systems Consumption Value by Region (2021-2026) & (USD Million)
Table 140. Asia-Pacific Nuclear Medicine Radioisotope Production Systems Consumption Value by Region (2027-2032) & (USD Million)
Table 141. South America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2021-2026) & (Units)
Table 142. South America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2027-2032) & (Units)
Table 143. South America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2021-2026) & (Units)
Table 144. South America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2027-2032) & (Units)
Table 145. South America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Country (2021-2026) & (Units)
Table 146. South America Nuclear Medicine Radioisotope Production Systems Sales Quantity by Country (2027-2032) & (Units)
Table 147. South America Nuclear Medicine Radioisotope Production Systems Consumption Value by Country (2021-2026) & (USD Million)
Table 148. South America Nuclear Medicine Radioisotope Production Systems Consumption Value by Country (2027-2032) & (USD Million)
Table 149. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2021-2026) & (Units)
Table 150. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Quantity by Production Route (2027-2032) & (Units)
Table 151. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2021-2026) & (Units)
Table 152. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Quantity by Application (2027-2032) & (Units)
Table 153. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Quantity by Country (2021-2026) & (Units)
Table 154. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Quantity by Country (2027-2032) & (Units)
Table 155. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Consumption Value by Country (2021-2026) & (USD Million)
Table 156. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Consumption Value by Country (2027-2032) & (USD Million)
Table 157. Nuclear Medicine Radioisotope Production Systems Raw Material
Table 158. Key Manufacturers of Nuclear Medicine Radioisotope Production Systems Raw Materials
Table 159. Nuclear Medicine Radioisotope Production Systems Typical Distributors
Table 160. Nuclear Medicine Radioisotope Production Systems Typical Customers
LIST OF FIGURES
Figure 1. Nuclear Medicine Radioisotope Production Systems Picture
Figure 2. Global Nuclear Medicine Radioisotope Production Systems Revenue by Production Route, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Production Route in 2025
Figure 4. Cyclotron based Production Systems Examples
Figure 5. Reactor Irradiation Production Systems Examples
Figure 6. Generator and Separation Production Systems Examples
Figure 7. Electron Accelerator and Neutron Source Production Systems Examples
Figure 8. Others Examples
Figure 9. Global Nuclear Medicine Radioisotope Production Systems Revenue by Energy Level, (USD Million), 2021 & 2025 & 2032
Figure 10. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Energy Level in 2025
Figure 11. Compact Low Energy Systems (?20 MeV) Examples
Figure 12. Medium Energy Multi Isotope Systems (20 to 35 MeV) Examples
Figure 13. High Energy Isotope Production Systems (>35 MeV) Examples
Figure 14. Others Examples
Figure 15. Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 16. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Application in 2025
Figure 17. Hospital Nuclear Medicine Centers Examples
Figure 18. Commercial Radiopharmacies Examples
Figure 19. National Isotope Production Centers Examples
Figure 20. Research Institutes and Universities Examples
Figure 21. Nuclear Reactor Facilities Examples
Figure 22. Radiopharmaceutical CDMO Sites Examples
Figure 23. Others Examples
Figure 24. Global Nuclear Medicine Radioisotope Production Systems Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 25. Global Nuclear Medicine Radioisotope Production Systems Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 26. Global Nuclear Medicine Radioisotope Production Systems Sales Quantity (2021-2032) & (Units)
Figure 27. Global Nuclear Medicine Radioisotope Production Systems Price (2021-2032) & (K US$/Unit)
Figure 28. Global Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Manufacturer in 2025
Figure 29. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Manufacturer in 2025
Figure 30. Producer Shipments of Nuclear Medicine Radioisotope Production Systems by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 31. Top 3 Nuclear Medicine Radioisotope Production Systems Manufacturer (Revenue) Market Share in 2025
Figure 32. Top 6 Nuclear Medicine Radioisotope Production Systems Manufacturer (Revenue) Market Share in 2025
Figure 33. Global Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Region (2021-2032)
Figure 34. Global Nuclear Medicine Radioisotope Production Systems Consumption Value Market Share by Region (2021-2032)
Figure 35. North America Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 36. Europe Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 37. Asia-Pacific Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 38. South America Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 39. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 40. Global Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Production Route (2021-2032)
Figure 41. Global Nuclear Medicine Radioisotope Production Systems Consumption Value Market Share by Production Route (2021-2032)
Figure 42. Global Nuclear Medicine Radioisotope Production Systems Average Price by Production Route (2021-2032) & (K US$/Unit)
Figure 43. Global Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Application (2021-2032)
Figure 44. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Application (2021-2032)
Figure 45. Global Nuclear Medicine Radioisotope Production Systems Average Price by Application (2021-2032) & (K US$/Unit)
Figure 46. North America Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Production Route (2021-2032)
Figure 47. North America Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Application (2021-2032)
Figure 48. North America Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Country (2021-2032)
Figure 49. North America Nuclear Medicine Radioisotope Production Systems Consumption Value Market Share by Country (2021-2032)
Figure 50. United States Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 51. Canada Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 52. Mexico Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 53. Europe Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Production Route (2021-2032)
Figure 54. Europe Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Application (2021-2032)
Figure 55. Europe Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Country (2021-2032)
Figure 56. Europe Nuclear Medicine Radioisotope Production Systems Consumption Value Market Share by Country (2021-2032)
Figure 57. Germany Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 58. France Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 59. United Kingdom Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 60. Russia Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 61. Italy Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 62. Asia-Pacific Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Production Route (2021-2032)
Figure 63. Asia-Pacific Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Application (2021-2032)
Figure 64. Asia-Pacific Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Region (2021-2032)
Figure 65. Asia-Pacific Nuclear Medicine Radioisotope Production Systems Consumption Value Market Share by Region (2021-2032)
Figure 66. China Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 67. Japan Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 68. South Korea Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 69. India Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 70. Southeast Asia Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 71. Australia Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 72. South America Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Production Route (2021-2032)
Figure 73. South America Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Application (2021-2032)
Figure 74. South America Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Country (2021-2032)
Figure 75. South America Nuclear Medicine Radioisotope Production Systems Consumption Value Market Share by Country (2021-2032)
Figure 76. Brazil Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 77. Argentina Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 78. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Production Route (2021-2032)
Figure 79. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Application (2021-2032)
Figure 80. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Country (2021-2032)
Figure 81. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Consumption Value Market Share by Country (2021-2032)
Figure 82. Turkey Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 83. Egypt Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 84. Saudi Arabia Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 85. South Africa Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 86. Nuclear Medicine Radioisotope Production Systems Market Drivers
Figure 87. Nuclear Medicine Radioisotope Production Systems Market Restraints
Figure 88. Nuclear Medicine Radioisotope Production Systems Market Trends
Figure 89. Porters Five Forces Analysis
Figure 90. Manufacturing Cost Structure Analysis of Nuclear Medicine Radioisotope Production Systems in 2025
Figure 91. Manufacturing Process Analysis of Nuclear Medicine Radioisotope Production Systems
Figure 92. Nuclear Medicine Radioisotope Production Systems Industrial Chain
Figure 93. Sales Channel: Direct to End-User vs Distributors
Figure 94. Direct Channel Pros & Cons
Figure 95. Indirect Channel Pros & Cons
Figure 96. Methodology
Figure 97. Research Process and Data Source
Figure 1. Nuclear Medicine Radioisotope Production Systems Picture
Figure 2. Global Nuclear Medicine Radioisotope Production Systems Revenue by Production Route, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Production Route in 2025
Figure 4. Cyclotron based Production Systems Examples
Figure 5. Reactor Irradiation Production Systems Examples
Figure 6. Generator and Separation Production Systems Examples
Figure 7. Electron Accelerator and Neutron Source Production Systems Examples
Figure 8. Others Examples
Figure 9. Global Nuclear Medicine Radioisotope Production Systems Revenue by Energy Level, (USD Million), 2021 & 2025 & 2032
Figure 10. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Energy Level in 2025
Figure 11. Compact Low Energy Systems (?20 MeV) Examples
Figure 12. Medium Energy Multi Isotope Systems (20 to 35 MeV) Examples
Figure 13. High Energy Isotope Production Systems (>35 MeV) Examples
Figure 14. Others Examples
Figure 15. Global Nuclear Medicine Radioisotope Production Systems Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 16. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Application in 2025
Figure 17. Hospital Nuclear Medicine Centers Examples
Figure 18. Commercial Radiopharmacies Examples
Figure 19. National Isotope Production Centers Examples
Figure 20. Research Institutes and Universities Examples
Figure 21. Nuclear Reactor Facilities Examples
Figure 22. Radiopharmaceutical CDMO Sites Examples
Figure 23. Others Examples
Figure 24. Global Nuclear Medicine Radioisotope Production Systems Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 25. Global Nuclear Medicine Radioisotope Production Systems Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 26. Global Nuclear Medicine Radioisotope Production Systems Sales Quantity (2021-2032) & (Units)
Figure 27. Global Nuclear Medicine Radioisotope Production Systems Price (2021-2032) & (K US$/Unit)
Figure 28. Global Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Manufacturer in 2025
Figure 29. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Manufacturer in 2025
Figure 30. Producer Shipments of Nuclear Medicine Radioisotope Production Systems by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 31. Top 3 Nuclear Medicine Radioisotope Production Systems Manufacturer (Revenue) Market Share in 2025
Figure 32. Top 6 Nuclear Medicine Radioisotope Production Systems Manufacturer (Revenue) Market Share in 2025
Figure 33. Global Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Region (2021-2032)
Figure 34. Global Nuclear Medicine Radioisotope Production Systems Consumption Value Market Share by Region (2021-2032)
Figure 35. North America Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 36. Europe Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 37. Asia-Pacific Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 38. South America Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 39. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 40. Global Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Production Route (2021-2032)
Figure 41. Global Nuclear Medicine Radioisotope Production Systems Consumption Value Market Share by Production Route (2021-2032)
Figure 42. Global Nuclear Medicine Radioisotope Production Systems Average Price by Production Route (2021-2032) & (K US$/Unit)
Figure 43. Global Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Application (2021-2032)
Figure 44. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Application (2021-2032)
Figure 45. Global Nuclear Medicine Radioisotope Production Systems Average Price by Application (2021-2032) & (K US$/Unit)
Figure 46. North America Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Production Route (2021-2032)
Figure 47. North America Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Application (2021-2032)
Figure 48. North America Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Country (2021-2032)
Figure 49. North America Nuclear Medicine Radioisotope Production Systems Consumption Value Market Share by Country (2021-2032)
Figure 50. United States Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 51. Canada Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 52. Mexico Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 53. Europe Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Production Route (2021-2032)
Figure 54. Europe Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Application (2021-2032)
Figure 55. Europe Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Country (2021-2032)
Figure 56. Europe Nuclear Medicine Radioisotope Production Systems Consumption Value Market Share by Country (2021-2032)
Figure 57. Germany Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 58. France Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 59. United Kingdom Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 60. Russia Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 61. Italy Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 62. Asia-Pacific Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Production Route (2021-2032)
Figure 63. Asia-Pacific Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Application (2021-2032)
Figure 64. Asia-Pacific Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Region (2021-2032)
Figure 65. Asia-Pacific Nuclear Medicine Radioisotope Production Systems Consumption Value Market Share by Region (2021-2032)
Figure 66. China Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 67. Japan Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 68. South Korea Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 69. India Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 70. Southeast Asia Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 71. Australia Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 72. South America Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Production Route (2021-2032)
Figure 73. South America Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Application (2021-2032)
Figure 74. South America Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Country (2021-2032)
Figure 75. South America Nuclear Medicine Radioisotope Production Systems Consumption Value Market Share by Country (2021-2032)
Figure 76. Brazil Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 77. Argentina Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 78. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Production Route (2021-2032)
Figure 79. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Application (2021-2032)
Figure 80. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Quantity Market Share by Country (2021-2032)
Figure 81. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Consumption Value Market Share by Country (2021-2032)
Figure 82. Turkey Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 83. Egypt Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 84. Saudi Arabia Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 85. South Africa Nuclear Medicine Radioisotope Production Systems Consumption Value (2021-2032) & (USD Million)
Figure 86. Nuclear Medicine Radioisotope Production Systems Market Drivers
Figure 87. Nuclear Medicine Radioisotope Production Systems Market Restraints
Figure 88. Nuclear Medicine Radioisotope Production Systems Market Trends
Figure 89. Porters Five Forces Analysis
Figure 90. Manufacturing Cost Structure Analysis of Nuclear Medicine Radioisotope Production Systems in 2025
Figure 91. Manufacturing Process Analysis of Nuclear Medicine Radioisotope Production Systems
Figure 92. Nuclear Medicine Radioisotope Production Systems Industrial Chain
Figure 93. Sales Channel: Direct to End-User vs Distributors
Figure 94. Direct Channel Pros & Cons
Figure 95. Indirect Channel Pros & Cons
Figure 96. Methodology
Figure 97. Research Process and Data Source
